Hubert L. Allen
Net Worth

Last updated:

What is Hubert L. Allen net worth?

The estimated net worth of Mr. Hubert L. Allen is at least $78,557,473 as of 1 Mar 2024. He owns shares worth $24,303,837 as insider, has earned $32,413,636 from insider trading and has received compensation worth at least $21,840,000 in Abbott Laboratories.

What is the salary of Hubert L. Allen?

Mr. Hubert L. Allen salary is $1,820,000 per year as Executive Vice President, Gen. Counsel & Sec. in Abbott Laboratories.

How old is Hubert L. Allen?

Mr. Hubert L. Allen is 59 years old, born in 1966.

What stocks does Hubert L. Allen currently own?

As insider, Mr. Hubert L. Allen owns shares in one company:

Company Title Shares Price per share Total value
Abbott Laboratories (ABT) Executive Vice President, Gen. Counsel & Sec. 184,806 $131.51 $24,303,837

What does Abbott Laboratories do?

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Hubert L. Allen insider trading

Abbott Laboratories

Mr. Hubert L. Allen has made 17 insider trades between 2013-2024, according to the Form 4 filled with the SEC. Most recently he sold 853 units of ABT stock worth $101,081 on 1 Mar 2024.

The largest trade he's ever made was exercising 203,393 units of ABT stock on 1 Feb 2021. As of 1 Mar 2024 he still owns at least 184,806 units of ABT stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common shares without par value 853 $118.5 $101,081
Sale
Common shares without par value 1,069 $100.7 $107,648
Sale
Common shares without par value 1,450 $118.17 $171,348
Option
Common shares without par value 203,393 $38.76 $7,883,513
Option
Common shares without par value 95,600 $38.4 $3,671,040
Sale
Common shares without par value 2,050 $124.03 $254,257
Sale
Common shares without par value 203,393 $123.75 $25,169,274
Option
Option (right to buy) 203,393 $38.76 $7,883,513
Sale
Common shares without par value 1,208 $77.89 $94,091
Option
Common shares without par value 165,000 $34.94 $5,765,100
Option
Option (right to buy) 165,000 $34.94 $5,765,100
Sale
Common shares without par value 165,000 $34.94 $5,765,100
Sale
Common shares without par value 2,246 $78 $175,188
Option
Option (right to buy) 4,600 $26.7 $122,806
Option
Common shares without par value 4,600 $26.7 $122,806
Sale
Common shares without par value 4,600 $50.79 $233,643
Sale
Common shares without par value 857 $45.01 $38,569
Sale
Common shares without par value 3,400 $25.25 $85,836
Option
Common shares without par value 3,400 $25.25 $85,836
Option
Option (right to buy) 3,400 $25.25 $85,836
Option
Option (right to buy) 3,400 $20.75 $70,547
Option
Common shares without par value 3,400 $20.75 $70,547
Sale
Common shares without par value 3,400 $20.75 $70,547
Sale
Common shares without par value 1,543 $39.29 $60,618
Sale
Common shares without par value 172 $46.38 $7,978
Sale
Common shares without par value 1,543 $39.03 $60,229
Sale
Common shares without par value 333 $39.07 $13,009
Sale
Common shares without par value 146 $35.75 $5,220

Abbott Laboratories key executives

Abbott Laboratories executives and other stock owners filed with the SEC: